Psyllid ID: psy3330


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------61
MNYFLTCIFLILALTKLNKAICPSRCQCFDQKLEASCTDAGLEVVPIQLNPEVQTIILRENRISNVHYTLSFYIELRSLDLSVNKINVLGSHNFEYQNKLLNLNISYNEISALSKDTFKGLKELKTLDLSYNKISVINKTAFRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKLDNNQILDVPNNVLSNLPHQSLHYLYLNENLIETVLDNSFPFTLTNLHTLALSSNIISFINESSFVTLRTLHSLDLSNNNLSAIPTKQLSKLSALVNLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQPLSLSLPPLLLSLSIPLAFSLTPLGTLKCDRLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQRAFVDNIQLETVIINENMNLKQLPSKLFQGNTNLKSVSLKGNSLSHLEASHFPLERISFLDLSDNPLHCDCNLLWLWILVQLQVKSTMETTTVAYEMTSNTSISPGTTTEAQRVDRIIKNNHSLTIVLNNLKCSSPPDIKGLEVKAVPENSVHCESNTMLYVLSFMLLLLSSGVICILMYFIYRKRALWKNKINRNLKHQSSYVDNCMNSHPTPILMLYSTGDSDAI
ccHHHHHHHHHHHHccccccccccccEEcccccEEEEcccccccccccccccccEEEccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccccccHHHccccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccccEEEccccccccccccccccccccccccEEccccccccccccccHHccccccEEEcccccccccccHHccccccccEEEccccccccccHHHHcccccccEEEccccccccccHHHHcccccccEEEccccccccccccccccccccccccccccccccccccccccccEEEccccccccccHHHccccccccEEEccccccccccccccccccccccEEEccccccccccccccccccccccEEEccccccccccccccccccccEEEccccccccccccHHHHHHHHHHHccccccccccccccccccccccccccHHHHHHHHHcccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccEEEEEEccccccc
ccHHHHHHHHHHccccccccccccccccccccEEEEEccccccccccccccccEEEEccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHHcccccccEEEccccccccccHHHHccccHHcccEEEccccccccccccccccccccccEEEEEEEEEcccHHHcccccccccEEEccccccccccHHHHcccccccEEEcccccccEEccccccccccccEEEcccccccccccHHHcccccHHEEEccccccccccccccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHHcccccccEEEcccccccccccHHHHHccccccEEEccccccccccHHHcccccccEEEcccccccccccHHHHHHHHHHccccccccccccccHHHHHHccccccccccccccccccccEEEcccccccccccHHHcccccccEEccccccccccccHHHccHHHHHHHHHHHHHHHHHcHcccccHcHcccccccccccccccccccccEEEEEEcccccccc
MNYFLTCIFLILALTKLnkaicpsrcqcfdqKLEAsctdaglevvpiqlnpevqTIILRENRISNVHYTLSFYIELRSLDLSVNKINVLGSHNFEYQNKLLNLNISYNEISALSKDTFKGLKElktldlsynkISVINKTAFRDTLHLELLILSfnnityfedseIFSSLKSLRIlkldnnqildvpnnvlsnlphqslhYLYLNENLIetvldnsfpftltNLHTLALSSNIISFINESSFVTLRTLHSLdlsnnnlsaiptkqLSKLSALVNldlsgnnfsnidSVAFKSLFSLKLVKInlipnldsidqplslslpplllslsiplafsltplgtlkcdrldlsgnnfsnidSVAFKSLFSLKLVKInlipnldsidqrafvdnIQLETVIINenmnlkqlpsklfqgntnlksvslkgnslshleashfplerisfldlsdnplhcdcnlLWLWILVQLQVKSTMETTTVAYEmtsntsispgttteAQRVDRIIKNNHSLTIVLNnlkcssppdikglevkavpensvhcesnTMLYVLSFMLLLLSSGVICILMYFIYRKRALWKNKINRNLKHqssyvdncmnshptpilmlystgdsdai
MNYFLTCIFLILALTKLNKAICPSRCQCFDQKLEASCTDAGLEVVPIQLNPEVQTIILRENRISNVHYTLSFYIELRSLDLSVNKINVLGSHNFEYQNKLLNLNISYNEISALSKDTFKGLKELKTLDLSYNKISVINKTAFRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKLDNNQILDVPNNVLSNLPHQSLHYLYLNENLIETVLDNSFPFTLTNLHTLALSSNIISFINESSFVTLRTLHSLDLSNNNLSAIPTKQLSKLSALVNLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQPLSLSLPPLLLSLSIPLAFSLTPLGTLKCDRLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQRAFVDNIQLETVIINENMNLKQLPSKLFQGNTNLKSVSLKGNSLSHLEASHFPLERISFLDLSDNPLHCDCNLLWLWILVQLQVKSTMETTTVAYemtsntsispgtttEAQRVDRIIKNNHSLTIVLNNLKCSSPPDIKGLEVKAVPENSVHCESNTMLYVLSFMLLLLSSGVICILMYFIYRKRALWKNKINRNLKHQSSYVDNCMNSHPTPILmlystgdsdai
MNYFLTCIFLILALTKLNKAICPSRCQCFDQKLEASCTDAGLEVVPIQLNPEVQTIILRENRISNVHYTLSFYIELRSLDLSVNKINVLGSHNFEYQNKLLNLNISYNEISALSKDTFKGLKELKTLDLSYNKISVINKTAFRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKLDNNQILDVPNNVLSNLPHQSLHYLYLNENLIETVLDNSFPFTLTNLHTLALssniisfinessfVTLRTLHsldlsnnnlsAIPTKQLSKLSALVNLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQplslslpplllslsiplAFSLTPLGTLKCDRLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQRAFVDNIQLETVIINENMNLKQLPSKLFQGNTNLKSVSLKGNSLSHLEASHFPLERISFLDLSDNPLHCDCNllwlwilvqlqvKSTMETTTVAYEMTSNTSISPGTTTEAQRVDRIIKNNHSLTIVLNNLKCSSPPDIKGLEVKAVPENSVHCESNTMlyvlsfmllllssGVICILMYFIYRKRALWKNKINRNLKHQSSYVDNCMNSHPTPILMLYSTGDSDAI
**YFLTCIFLILALTKLNKAICPSRCQCFDQKLEASCTDAGLEVVPIQLNPEVQTIILRENRISNVHYTLSFYIELRSLDLSVNKINVLGSHNFEYQNKLLNLNISYNEISALSKDTFKGLKELKTLDLSYNKISVINKTAFRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKLDNNQILDVPNNVLSNLPHQSLHYLYLNENLIETVLDNSFPFTLTNLHTLALSSNIISFINESSFVTLRTLHSLDLSNNNLSAIPTKQLSKLSALVNLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQPLSLSLPPLLLSLSIPLAFSLTPLGTLKCDRLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQRAFVDNIQLETVIINENMNLKQLPSKLFQGNTNLK*V*L****LSHLEASHFPLERISFLDLSDNPLHCDCNLLWLWILVQLQVKSTMETTTVAYEM***************RVDRIIKNNHSLTIVLNNLKCSSPPDIKGLEVKAVPENSVHCESNTMLYVLSFMLLLLSSGVICILMYFIYRKRALWKNKINRNLKHQSSYVDNCMNSHPTPILMLY********
MNYFLTCIFLILALTKLNKAICPSRCQCFDQKLEASCTDAGLEVVPIQLNPEVQTIILRENRISNVHYTLSFYIELRSLDLSVNKINVLGSHNFEYQNKLLNLNISYNEISALSKDTFKGLKELKTLDLSYNKISVINKTAFRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKLDNNQILDVPNNVLSNLPHQSLHYLYLNENLIETVLDNSFPFTLTNLHTLALSSNIISFINESSFVTLRTLHSLDLSNNNLSAIPTKQLSKLSALVNLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQPLSLSLPPLLLSLSIPLAFSLTPLGTLKCDRLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQRAFVDNIQLETVIINENMNLKQLPSKLFQGNTNLKSVSLKGNSLSHLEASHFPLERISFLDLSDNPLHCDCNLLWLWILVQLQVKSTMETTTVAYEMTSNTSISPGTTTEAQRVDRIIKNNHSLTIVLNNLKCSSPPDIKGLEVKAVPENSVHCESNTMLYVLSFMLLLLSSGVICILMYFIYRKRALWKNKINRNLKHQSSYVDNCMNSHPTPILMLYSTGD****
MNYFLTCIFLILALTKLNKAICPSRCQCFDQKLEASCTDAGLEVVPIQLNPEVQTIILRENRISNVHYTLSFYIELRSLDLSVNKINVLGSHNFEYQNKLLNLNISYNEISALSKDTFKGLKELKTLDLSYNKISVINKTAFRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKLDNNQILDVPNNVLSNLPHQSLHYLYLNENLIETVLDNSFPFTLTNLHTLALSSNIISFINESSFVTLRTLHSLDLSNNNLSAIPTKQLSKLSALVNLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQPLSLSLPPLLLSLSIPLAFSLTPLGTLKCDRLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQRAFVDNIQLETVIINENMNLKQLPSKLFQGNTNLKSVSLKGNSLSHLEASHFPLERISFLDLSDNPLHCDCNLLWLWILVQLQVKSTMETTTVAYEMTSNTSISPGTTTEAQRVDRIIKNNHSLTIVLNNLKCSSPPDIKGLEVKAVPENSVHCESNTMLYVLSFMLLLLSSGVICILMYFIYRKRALWKNKINRNLKHQSSYVDNCMNSHPTPILMLYSTGDSDAI
MNYFLTCIFLILALTKLNKAICPSRCQCFDQKLEASCTDAGLEVVPIQLNPEVQTIILRENRISNVHYTLSFYIELRSLDLSVNKINVLGSHNFEYQNKLLNLNISYNEISALSKDTFKGLKELKTLDLSYNKISVINKTAFRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKLDNNQILDVPNNVLSNLPHQSLHYLYLNENLIETVLDNSFPFTLTNLHTLALSSNIISFINESSFVTLRTLHSLDLSNNNLSAIPTKQLSKLSALVNLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQPLSLSLPPLLLSLSIPLAFSLTPLGTLKCDRLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQRAFVDNIQLETVIINENMNLKQLPSKLFQGNTNLKSVSLKGNSLSHLEASHFPLERISFLDLSDNPLHCDCNLLWLWILVQLQVKSTMETTTVAYEMTSNTSISPGTTTEAQRVDRIIKNNHSLTIVLNNLKCSSPPDIKGLEVKAVPENSVHCESNTMLYVLSFMLLLLSSGVICILMYFIYRKRALWKNKINRNLKHQSSYVDNCMNSHPTPILMLYSTG*****
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
SSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MNYFLTCIFLILALTKLNKAICPSRCQCFDQKLEASCTDAGLEVVPIQLNPEVQTIILRENRISNVHYTLSFYIELRSLDLSVNKINVLGSHNFEYQNKLLNLNISYNEISALSKDTFKGLKELKTLDLSYNKISVINKTAFRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKLDNNQILDVPNNVLSNLPHQSLHYLYLNENLIETVLDNSFPFTLTNLHTLALSSNIISFINESSFVTLRTLHSLDLSNNNLSAIPTKQLSKLSALVNLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQPLSLSLPPLLLSLSIPLAFSLTPLGTLKCDRLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQRAFVDNIQLETVIINENMNLKQLPSKLFQGNTNLKSVSLKGNSLSHLEASHFPLERISFLDLSDNPLHCDCNLLWLWILVQLQVKSTMETTTVAYEMTSNTSISPGTTTEAQRVDRIIKNNHSLTIVLNNLKCSSPPDIKGLEVKAVPENSVHCESNTMLYVLSFMLLLLSSGVICILMYFIYRKRALWKNKINRNLKHQSSYVDNCMNSHPTPILMLYSTGDSDAI
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query608 2.2.26 [Sep-21-2011]
Q7L985606 Leucine-rich repeat and i yes N/A 0.519 0.521 0.318 5e-24
Q3URE9606 Leucine-rich repeat and i yes N/A 0.506 0.508 0.330 6e-24
Q50L44613 Leucine-rich repeat and i no N/A 0.508 0.504 0.302 3e-23
Q9D1T0614 Leucine-rich repeat and i no N/A 0.508 0.503 0.302 4e-23
Q9N008614 Leucine-rich repeat and i N/A N/A 0.508 0.503 0.302 5e-23
P35858605 Insulin-like growth facto no N/A 0.820 0.824 0.265 6e-23
Q5RDJ4614 Leucine-rich repeat and i no N/A 0.508 0.503 0.302 9e-23
Q96FE5620 Leucine-rich repeat and i no N/A 0.508 0.498 0.302 1e-22
O02833605 Insulin-like growth facto N/A N/A 0.669 0.672 0.275 1e-22
Q7L0X0 811 TLR4 interactor with leuc no N/A 0.463 0.347 0.294 5e-22
>sp|Q7L985|LIGO2_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 OS=Homo sapiens GN=LINGO2 PE=1 SV=1 Back     alignment and function desciption
 Score =  113 bits (282), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 111/349 (31%), Positives = 173/349 (49%), Gaps = 33/349 (9%)

Query: 123 ELKTLDLSYNKISVINKTAFRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKLDNNQ 182
           E K LDLS N++  +N   F     LE + LS N I   E    F++L +LR L+L  N+
Sbjct: 58  ETKILDLSKNRLKSVNPEEFISYPLLEEIDLSDNIIANVEPGA-FNNLFNLRSLRLKGNR 116

Query: 183 ILDVPNNVLSNLPHQSLHYLYLNENLIETVLDNSFPFTLTNLHTLALSSNIISFINESSF 242
           +  VP  V + L   +L  L ++EN I  +LD  F   L NL +L +  N + +I+  +F
Sbjct: 117 LKLVPLGVFTGL--SNLTKLDISENKIVILLDYMFQ-DLHNLKSLEVGDNDLVYISHRAF 173

Query: 243 VTLRTLHSLDLSNNNLSAIPTKQLSKLSALVNLDLSGNNFSNIDSVAFKSLFSLKLVKIN 302
             L +L  L L   NL+A+PT+ LS L +L++L L   N +N+   AFK LF LK ++I+
Sbjct: 174 SGLLSLEQLTLEKCNLTAVPTEALSHLRSLISLHLKHLNINNMPVYAFKRLFHLKHLEID 233

Query: 303 LIPNLDSIDQPLSLSLPPLLLSLSIPLAFSLTPLGTLKCDRLDLSGNNFSNIDSVAFKSL 362
             P LD +                         L  L    L ++  N S +  +AFK L
Sbjct: 234 YWPLLDMMPA---------------------NSLYGLNLTSLSVTNTNLSTVPFLAFKHL 272

Query: 363 FSLKLVKINLIPNLDSIDQRAFVDNIQLETVIINENMNLKQLPSKLFQGNTNLKSVSLKG 422
             L  + ++  P + +I+   F D I+L+ + I     L+ +    FQG   L+ +++  
Sbjct: 273 VYLTHLNLSYNP-ISTIEAGMFSDLIRLQELHI-VGAQLRTIEPHSFQGLRFLRVLNVSQ 330

Query: 423 NSLSHLEASHFPLER-ISFLDLSDNPLHCDCNLLWLWILVQLQVKSTME 470
           N L  LE + F   R +  L +++NPL CDC LLW+     LQ + T++
Sbjct: 331 NLLETLEENVFSSPRALEVLSINNNPLACDCRLLWI-----LQRQPTLQ 374





Homo sapiens (taxid: 9606)
>sp|Q3URE9|LIGO2_MOUSE Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 OS=Mus musculus GN=Lingo2 PE=2 SV=1 Back     alignment and function description
>sp|Q50L44|LIGO1_CHICK Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 OS=Gallus gallus GN=LINGO1 PE=2 SV=1 Back     alignment and function description
>sp|Q9D1T0|LIGO1_MOUSE Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 OS=Mus musculus GN=Lingo1 PE=1 SV=1 Back     alignment and function description
>sp|Q9N008|LIGO1_MACFA Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 OS=Macaca fascicularis GN=LINGO1 PE=2 SV=1 Back     alignment and function description
>sp|P35858|ALS_HUMAN Insulin-like growth factor-binding protein complex acid labile subunit OS=Homo sapiens GN=IGFALS PE=1 SV=1 Back     alignment and function description
>sp|Q5RDJ4|LIGO1_PONAB Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 OS=Pongo abelii GN=LINGO1 PE=2 SV=1 Back     alignment and function description
>sp|Q96FE5|LIGO1_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 OS=Homo sapiens GN=LINGO1 PE=1 SV=2 Back     alignment and function description
>sp|O02833|ALS_PAPHA Insulin-like growth factor-binding protein complex acid labile subunit OS=Papio hamadryas GN=IGFALS PE=2 SV=1 Back     alignment and function description
>sp|Q7L0X0|TRIL_HUMAN TLR4 interactor with leucine rich repeats OS=Homo sapiens GN=TRIL PE=1 SV=2 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query608
157134290610 tartan [Aedes aegypti] gi|108881391|gb|E 0.784 0.781 0.341 7e-70
157134286673 tartan [Aedes aegypti] gi|108881389|gb|E 0.631 0.570 0.380 3e-68
195382037 763 GJ21757 [Drosophila virilis] gi|19414453 0.605 0.482 0.402 1e-65
195025204 803 GH21135 [Drosophila grimshawi] gi|193902 0.606 0.459 0.398 2e-65
158287359398 AGAP011229-PA [Anopheles gambiae str. PE 0.601 0.919 0.384 1e-64
383856948611 PREDICTED: insulin-like growth factor-bi 0.759 0.756 0.308 7e-64
161077348 738 Fish-lips, isoform C [Drosophila melanog 0.605 0.498 0.393 2e-62
322783005624 hypothetical protein SINV_01095 [Solenop 0.759 0.740 0.306 2e-62
307194209645 Leucine-rich repeat and immunoglobulin-l 0.634 0.598 0.341 3e-62
332024975645 Leucine-rich repeat and immunoglobulin-l 0.631 0.595 0.350 3e-62
>gi|157134290|ref|XP_001663226.1| tartan [Aedes aegypti] gi|108881391|gb|EAT45616.1| AAEL003111-PA [Aedes aegypti] Back     alignment and taxonomy information
 Score =  271 bits (693), Expect = 7e-70,   Method: Compositional matrix adjust.
 Identities = 192/562 (34%), Positives = 280/562 (49%), Gaps = 85/562 (15%)

Query: 10  LILALTKLNKAICPSRCQC-FDQKLEASCTDAGLEVVPIQLNPEVQTIILRENRISNVHY 68
           ++L   +   + CPS C C    K    C  AGL+VVPIQLNP+V+ I L  NRI+NVH+
Sbjct: 22  ILLVFLRQVYSFCPSICTCEVHPKARTWCIGAGLDVVPIQLNPDVRYINLTSNRITNVHF 81

Query: 69  TLSFYIELRSLDLSVNKINVLGSHNFEYQNKLLNLNISYNEISALSKDTFKGLKELKTLD 128
           TLSFY +L  LD+S NKI  LGS NFE+Q+ L  LN+S N I  + KD FKGL+ L+ L 
Sbjct: 82  TLSFYHKLEVLDISCNKIEALGSKNFEFQHDLRMLNMSDNAIVDIPKDAFKGLERLQILK 141

Query: 129 LSYNKISVINKTAFRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKLDNNQILDVPN 188
           L  N+I  I+ TAF D  +L  L  S N I   E   +   L SL  L   NNQ+L++P 
Sbjct: 142 LCNNRIETIHATAFHDLRNLLELDFSNNAIISLEHGTL-RHLYSLEWLSFQNNQVLEIPY 200

Query: 189 NVLSNLPHQSLHYLYLNENLIETVLDNSFPFTLTNLHTLALSSNIISFINESSFVTLRTL 248
           +   NL H                        L+ L +L LS N+I FI   SFV LR L
Sbjct: 201 D--RNLEH------------------------LSRLQSLDLSVNLIEFIANDSFVNLREL 234

Query: 249 HSLDLSNNNLSAIPTKQLSKLSALVNLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLD 308
             L L  N L+ +       L+AL  LDL+ NNF+ + ++    L +L            
Sbjct: 235 RMLKLGGNVLTELDYGAFHGLNALRALDLADNNFTIVPTLQLSKLCNLTY---------- 284

Query: 309 SIDQPLSLSLPPLLLSLSIPLAFSLTPLGTLKCDRLDLSGNNFSNIDSVAFKSLFSLKLV 368
                                              L LSGNNF  + +VAF +LF L+ +
Sbjct: 285 -----------------------------------LSLSGNNFEMLPAVAFLNLFQLRQL 309

Query: 369 KINLIPNLDSIDQRAFVDNIQLETVIINENMNLKQLPSKLFQGNTNLKSVSLKGNSLSHL 428
            ++ +  L+ ID RAFVDN  L TV +++N +   LP +L+ GN +L  +S++ N+L  L
Sbjct: 310 HLDRLDRLERIDVRAFVDNTNLHTVTLDDNPSFTSLPLRLWHGNPHLVEISMRRNALVRL 369

Query: 429 EASHFPLERISFLDLSDNPLHCDCNLLWLWILVQLQVKSTMETTTVAYEMTSNTSISPGT 488
           +A  FPL+R+  L L+ NPL C+C+LLWLW LV  +     E    +  +TS     P  
Sbjct: 370 DAVQFPLDRLHRLRLAGNPLVCNCSLLWLWRLVA-ESDPDDEFLLTSAALTSAGYAGPSN 428

Query: 489 TTEAQRVDRIIKNNHSLTIVLNNLKCSSPPDIKGLE--VKAVPENSVHCESNTMLYVLS- 545
             E         ++H+L I  + L C    D + +   ++ + E+ ++C ++ +  + + 
Sbjct: 429 DEET--------SSHALIIDRDELGCDLYEDGRKIRRTLRTMTESDLNCPTHVLTVISAV 480

Query: 546 FMLLLLSSGVICILMYFIYRKR 567
           F +LL+ +    +L +F   KR
Sbjct: 481 FSILLVLATAASVLYFFRLSKR 502




Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|157134286|ref|XP_001663224.1| tartan [Aedes aegypti] gi|108881389|gb|EAT45614.1| AAEL003115-PA [Aedes aegypti] Back     alignment and taxonomy information
>gi|195382037|ref|XP_002049739.1| GJ21757 [Drosophila virilis] gi|194144536|gb|EDW60932.1| GJ21757 [Drosophila virilis] Back     alignment and taxonomy information
>gi|195025204|ref|XP_001986021.1| GH21135 [Drosophila grimshawi] gi|193902021|gb|EDW00888.1| GH21135 [Drosophila grimshawi] Back     alignment and taxonomy information
>gi|158287359|ref|XP_309414.4| AGAP011229-PA [Anopheles gambiae str. PEST] gi|157019612|gb|EAA05167.4| AGAP011229-PA [Anopheles gambiae str. PEST] Back     alignment and taxonomy information
>gi|383856948|ref|XP_003703968.1| PREDICTED: insulin-like growth factor-binding protein complex acid labile subunit-like [Megachile rotundata] Back     alignment and taxonomy information
>gi|161077348|ref|NP_001097402.1| Fish-lips, isoform C [Drosophila melanogaster] gi|442624434|ref|NP_611619.2| Fish-lips, isoform D [Drosophila melanogaster] gi|54650582|gb|AAV36870.1| RE58108p [Drosophila melanogaster] gi|157400437|gb|ABV53873.1| Fish-lips, isoform C [Drosophila melanogaster] gi|440214573|gb|AAF46774.2| Fish-lips, isoform D [Drosophila melanogaster] Back     alignment and taxonomy information
>gi|322783005|gb|EFZ10717.1| hypothetical protein SINV_01095 [Solenopsis invicta] Back     alignment and taxonomy information
>gi|307194209|gb|EFN76626.1| Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 [Harpegnathos saltator] Back     alignment and taxonomy information
>gi|332024975|gb|EGI65162.1| Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 [Acromyrmex echinatior] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query608
FB|FBgn0085397 738 Fili "Fish-lips" [Drosophila m 0.491 0.405 0.412 1.6e-48
FB|FBgn0010452 737 trn "tartan" [Drosophila melan 0.458 0.378 0.341 1e-34
FB|FBgn0023095 748 caps "capricious" [Drosophila 0.480 0.390 0.309 2.2e-30
WB|WBGene00004854 1410 slt-1 [Caenorhabditis elegans 0.296 0.127 0.297 2.5e-24
UNIPROTKB|F1NI07604 IGFALS "Uncharacterized protei 0.600 0.604 0.261 2.6e-24
UNIPROTKB|F1MJZ4610 IGFALS "Uncharacterized protei 0.595 0.593 0.271 1.1e-23
UNIPROTKB|F1PSS7 1534 SLIT1 "Uncharacterized protein 0.320 0.127 0.291 1.4e-23
UNIPROTKB|O94813 1529 SLIT2 "Slit homolog 2 protein" 0.218 0.086 0.362 1.9e-12
UNIPROTKB|Q5T0V0 1461 SLIT1 "Slit homolog 1 protein" 0.320 0.133 0.281 5.3e-23
UNIPROTKB|F1P8A1 1530 SLIT2 "Uncharacterized protein 0.218 0.086 0.355 1.4e-11
FB|FBgn0085397 Fili "Fish-lips" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
 Score = 508 (183.9 bits), Expect = 1.6e-48, P = 1.6e-48
 Identities = 128/310 (41%), Positives = 174/310 (56%)

Query:     8 IFLILALTKL---NKAICPSRCQCF--DQKLEASCTDAGLEVVPIQLNPEVQTIILRENR 62
             + L+L L  L     A CPS+CQC   +    A C DA LE VPIQLNPE + I L  NR
Sbjct:    25 LLLLLTLVILPPETTAFCPSKCQCLGGEANSRALCVDAALEDVPIQLNPETKYINLTVNR 84

Query:    63 ISNVHYTLSFYIELRSLDLSVNKINVLGSHNFEYQNKLLNLNISYNEISALSKDTFKGLK 122
             I  + ++L FY++L  LDLS N I  LGS NFEYQ++L  LN+S N +S+L K  FKGL 
Sbjct:    85 IRTLEFSLPFYMKLEILDLSQNIIETLGSKNFEYQSELRTLNLSRNLVSSLHKHAFKGLT 144

Query:   123 ELKTLDLSYNKISVINKTAFRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKLDNNQ 182
              L  LDLS+N+I  ++ TA  D   L  L L+ NNI   ED+  F  + +L +L   NN+
Sbjct:   145 NLLLLDLSFNRIETVHPTALSDLASLVELDLTNNNIVSLEDN-CFKGMNTLEVLVFRNNR 203

Query:   183 ILDVPNNVLSNLPH-QSLHYLYLNENLIETVLDNSFPFTLTNLHTLALXXXXXXXXXXXX 241
             +LDVP    SNL H  +L  L ++ NL+E V ++SF   L  L  L++            
Sbjct:   204 LLDVP---ASNLWHLHALKSLDMSLNLVEFVRNDSFE-GLKELLALSVQGNVMSELDLSA 259

Query:   242 XVTLRTLHXXXXXXXXXXAIPTKQLSKLSALVNLDLSGNNFSNIDSVAFKSLFSLKLVKI 301
                L +L            +PT+QLSKLS L  L+L GN FS + +VAF +LF L+ + +
Sbjct:   260 FEGLISLKHLDLSDNNLTMVPTQQLSKLSNLTYLNLGGNRFSQLPAVAFLNLFHLRELHL 319

Query:   302 NLIPNLDSID 311
             + +  L  ID
Sbjct:   320 SRLDFLQRID 329


GO:0003674 "molecular_function" evidence=ND
GO:0042981 "regulation of apoptotic process" evidence=IMP
GO:0016021 "integral to membrane" evidence=ISM
GO:0007476 "imaginal disc-derived wing morphogenesis" evidence=IMP
FB|FBgn0010452 trn "tartan" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
FB|FBgn0023095 caps "capricious" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
WB|WBGene00004854 slt-1 [Caenorhabditis elegans (taxid:6239)] Back     alignment and assigned GO terms
UNIPROTKB|F1NI07 IGFALS "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|F1MJZ4 IGFALS "Uncharacterized protein" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
UNIPROTKB|F1PSS7 SLIT1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
UNIPROTKB|O94813 SLIT2 "Slit homolog 2 protein" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|Q5T0V0 SLIT1 "Slit homolog 1 protein" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|F1P8A1 SLIT2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query608
pfam1385560 pfam13855, LRR_8, Leucine rich repeat 4e-09
pfam1385560 pfam13855, LRR_8, Leucine rich repeat 8e-08
pfam1385560 pfam13855, LRR_8, Leucine rich repeat 1e-07
pfam1385560 pfam13855, LRR_8, Leucine rich repeat 2e-07
PLN00113 968 PLN00113, PLN00113, leucine-rich repeat receptor-l 3e-07
PLN00113 968 PLN00113, PLN00113, leucine-rich repeat receptor-l 4e-07
COG4886394 COG4886, COG4886, Leucine-rich repeat (LRR) protei 4e-07
PLN00113 968 PLN00113, PLN00113, leucine-rich repeat receptor-l 2e-06
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 4e-05
pfam1385560 pfam13855, LRR_8, Leucine rich repeat 7e-05
pfam1385560 pfam13855, LRR_8, Leucine rich repeat 1e-04
pfam1385560 pfam13855, LRR_8, Leucine rich repeat 4e-04
pfam13306128 pfam13306, LRR_5, Leucine rich repeats (6 copies) 4e-04
COG4886394 COG4886, COG4886, Leucine-rich repeat (LRR) protei 5e-04
PLN00113968 PLN00113, PLN00113, leucine-rich repeat receptor-l 0.002
>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat Back     alignment and domain information
 Score = 52.5 bits (127), Expect = 4e-09
 Identities = 23/57 (40%), Positives = 33/57 (57%)

Query: 102 NLNISYNEISALSKDTFKGLKELKTLDLSYNKISVINKTAFRDTLHLELLILSFNNI 158
           +L++S N ++ +    FKGL  LK LDLS N ++ I+  AF     L  L LS NN+
Sbjct: 4   SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60


Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat Back     alignment and domain information
>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat Back     alignment and domain information
>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat Back     alignment and domain information
>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat Back     alignment and domain information
>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat Back     alignment and domain information
>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat Back     alignment and domain information
>gnl|CDD|205486 pfam13306, LRR_5, Leucine rich repeats (6 copies) Back     alignment and domain information
>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 608
KOG4194|consensus 873 100.0
KOG4237|consensus498 100.0
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 100.0
KOG4194|consensus 873 100.0
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 100.0
KOG0472|consensus565 99.97
KOG0444|consensus 1255 99.96
KOG0472|consensus565 99.95
KOG0444|consensus 1255 99.94
KOG4237|consensus498 99.92
KOG0618|consensus 1081 99.92
PRK15387788 E3 ubiquitin-protein ligase SspH2; Provisional 99.91
KOG0618|consensus 1081 99.91
PLN032101153 Resistant to P. syringae 6; Provisional 99.86
PLN032101153 Resistant to P. syringae 6; Provisional 99.86
PRK15370754 E3 ubiquitin-protein ligase SlrP; Provisional 99.82
PRK15387788 E3 ubiquitin-protein ligase SspH2; Provisional 99.82
PRK15370754 E3 ubiquitin-protein ligase SlrP; Provisional 99.81
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.62
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.59
KOG0617|consensus264 99.57
KOG0617|consensus264 99.55
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 99.3
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 99.24
KOG1259|consensus490 99.21
KOG3207|consensus505 99.19
PLN03150623 hypothetical protein; Provisional 99.14
KOG3207|consensus505 99.14
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 99.1
KOG1909|consensus382 99.1
KOG0532|consensus 722 99.09
KOG0532|consensus 722 99.09
KOG0531|consensus414 99.06
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 99.04
KOG1259|consensus490 99.03
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 99.03
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 98.97
KOG1909|consensus382 98.93
KOG0531|consensus414 98.9
TIGR00864 2740 PCC polycystin cation channel protein. Note: this 98.77
KOG4658|consensus889 98.76
KOG4658|consensus889 98.74
PLN03150623 hypothetical protein; Provisional 98.68
KOG1859|consensus 1096 98.44
KOG1644|consensus233 98.43
KOG1859|consensus 1096 98.4
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 98.33
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 98.29
KOG1644|consensus233 98.24
KOG4579|consensus177 98.22
KOG2982|consensus418 98.21
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 98.15
smart0008251 LRRCT Leucine rich repeat C-terminal domain. 98.1
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 98.07
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 98.04
KOG2120|consensus419 97.98
KOG2982|consensus418 97.97
KOG4579|consensus177 97.97
PRK15386426 type III secretion protein GogB; Provisional 97.73
PRK15386426 type III secretion protein GogB; Provisional 97.7
KOG2120|consensus419 97.66
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 97.54
KOG3665|consensus699 97.39
smart0001333 LRRNT Leucine rich repeat N-terminal domain. 97.38
PF0146228 LRRNT: Leucine rich repeat N-terminal domain; Inte 97.3
KOG3665|consensus699 97.29
KOG2739|consensus260 97.19
KOG2123|consensus388 97.19
KOG2123|consensus388 96.68
KOG4341|consensus483 96.58
KOG4341|consensus483 96.13
KOG2739|consensus260 96.02
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 95.65
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 95.4
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 95.37
PF0146325 LRRCT: Leucine rich repeat C-terminal domain; Inte 94.97
smart0037026 LRR Leucine-rich repeats, outliers. 94.86
smart0036926 LRR_TYP Leucine-rich repeats, typical (most popula 94.86
KOG1947|consensus482 94.34
KOG1947|consensus482 93.85
smart0036926 LRR_TYP Leucine-rich repeats, typical (most popula 93.82
smart0037026 LRR Leucine-rich repeats, outliers. 93.82
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 93.04
KOG3864|consensus221 92.5
KOG0473|consensus326 92.42
KOG0473|consensus326 90.91
smart0036426 LRR_BAC Leucine-rich repeats, bacterial type. 88.13
KOG4308|consensus478 87.03
smart0036526 LRR_SD22 Leucine-rich repeat, SDS22-like subfamily 85.22
KOG3864|consensus221 82.47
>KOG4194|consensus Back     alignment and domain information
Probab=100.00  E-value=1.9e-55  Score=435.89  Aligned_cols=448  Identities=27%  Similarity=0.391  Sum_probs=399.7

Q ss_pred             CCCCCceecCCceEEEecCCCCccc-----cCccCccccEEEeccCCCccccc-ccccCCCccEEEeeCCCCcccCcccc
Q psy3330          21 ICPSRCQCFDQKLEASCTDAGLEVV-----PIQLNPEVQTIILRENRISNVHY-TLSFYIELRSLDLSVNKINVLGSHNF   94 (608)
Q Consensus        21 ~Cp~~C~c~~~~~~v~C~~~~l~~i-----p~~~~~~l~~L~L~~n~i~~l~~-~~~~~~~L~~L~Ls~n~l~~i~~~~f   94 (608)
                      .||..|.|.  ....+|++..+..+     +..+|+.++.|++++|++..+.. .|.++++|+.+++..|.++.||. .-
T Consensus        45 ~cpa~c~c~--~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~-f~  121 (873)
T KOG4194|consen   45 ECPATCPCN--TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPR-FG  121 (873)
T ss_pred             cCCCcCCCC--ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhccc-cc
Confidence            699999995  46899999999886     77789999999999999999875 67899999999999999999986 23


Q ss_pred             cccccccEEEccCCCCCCCChhhhcCCCcCcEeeccCCcCCccChhhhCCCCCCcEEEccCCCCCccCchhhhcCCCCcc
Q psy3330          95 EYQNKLLNLNISYNEISALSKDTFKGLKELKTLDLSYNKISVINKTAFRDTLHLELLILSFNNITYFEDSEIFSSLKSLR  174 (608)
Q Consensus        95 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~  174 (608)
                      +...+|+.|+|.+|.|+.+...++..++.|+.||||.|.|+.++...|..-.++++|+|++|.|+.+. .+.|.++.+|.
T Consensus       122 ~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~-~~~F~~lnsL~  200 (873)
T KOG4194|consen  122 HESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLE-TGHFDSLNSLL  200 (873)
T ss_pred             ccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccc-cccccccchhe
Confidence            44556999999999999999999999999999999999999999999999899999999999999998 89999999999


Q ss_pred             EEEccCCCCCCCCcccccCCCCCCceEEEccCCCCccccCCCccccCCCccEEEccCCCCCccCcccccCCCccCEEecc
Q psy3330         175 ILKLDNNQILDVPNNVLSNLPHQSLHYLYLNENLIETVLDNSFPFTLTNLHTLALSSNIISFINESSFVTLRTLHSLDLS  254 (608)
Q Consensus       175 ~L~L~~n~l~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  254 (608)
                      +|.|+.|+++.+|...|.++++  |+.|+|..|+|..+....|.+ +++|+.|.+..|.+..+..+.|.++.++++|+|+
T Consensus       201 tlkLsrNrittLp~r~Fk~L~~--L~~LdLnrN~irive~ltFqg-L~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~  277 (873)
T KOG4194|consen  201 TLKLSRNRITTLPQRSFKRLPK--LESLDLNRNRIRIVEGLTFQG-LPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLE  277 (873)
T ss_pred             eeecccCcccccCHHHhhhcch--hhhhhccccceeeehhhhhcC-chhhhhhhhhhcCcccccCcceeeecccceeecc
Confidence            9999999999999999999954  999999999999888888998 9999999999999999999999999999999999


Q ss_pred             CCcCCCCChhhhhCCCCCCEEeccCCCCCccChhhhCCCCCCceeeccCCCCCCCCCcccccCCchhhhccccccccccC
Q psy3330         255 NNNLSAIPTKQLSKLSALVNLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQPLSLSLPPLLLSLSIPLAFSLT  334 (608)
Q Consensus       255 ~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~l~~~~~l~~~~~~~~~~lp~~~~~~~~~~~~~~~  334 (608)
                      .|+++.+..+++.+++.|+.|++|+|.|..+...+|+.+++|+.|+|+.+. +..        +++.-+.          
T Consensus       278 ~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~-i~~--------l~~~sf~----------  338 (873)
T KOG4194|consen  278 TNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNR-ITR--------LDEGSFR----------  338 (873)
T ss_pred             cchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccc-ccc--------CChhHHH----------
Confidence            999999999999999999999999999999999999999999999996432 211        1111000          


Q ss_pred             CCCCceecEEecCCCCCCCcChhhhcccccccccccccCCCCCcC---ChhhhcCCcccceeecccCccccccCcccCCC
Q psy3330         335 PLGTLKCDRLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSI---DQRAFVDNIQLETVIINENMNLKQLPSKLFQG  411 (608)
Q Consensus       335 ~~~~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~l~l~~~~~l~~~---~~~~f~~l~~L~~L~Ls~N~~l~~lp~~~f~~  411 (608)
                        ....+++|+|++|.+..+...+|..+++|+.|+++. |.+...   ...+|.++++|+.|++.+|+ ++.||..+|.+
T Consensus       339 --~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~-N~ls~~IEDaa~~f~gl~~LrkL~l~gNq-lk~I~krAfsg  414 (873)
T KOG4194|consen  339 --VLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRS-NELSWCIEDAAVAFNGLPSLRKLRLTGNQ-LKSIPKRAFSG  414 (873)
T ss_pred             --HHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcC-CeEEEEEecchhhhccchhhhheeecCce-eeecchhhhcc
Confidence              011458999999999999999999999999999987 655432   45689999999999999998 99999999999


Q ss_pred             CCCCCEEEcCCCcccccCCCCCCCCCCCEEEccCCccccccCChHHHHHHHhhhccccccccceeccCCCccCCCCCccc
Q psy3330         412 NTNLKSVSLKGNSLSHLEASHFPLERISFLDLSDNPLHCDCNLLWLWILVQLQVKSTMETTTVAYEMTSNTSISPGTTTE  491 (608)
Q Consensus       412 l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~L~~N~~~CdC~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (608)
                      +++|+.|||.+|.|.+|.+..|.-..|++|-+..-.|-|||+++|+.+|+..+..                         
T Consensus       415 l~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~Wl~qWl~~~~l-------------------------  469 (873)
T KOG4194|consen  415 LEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQLKWLAQWLYRRKL-------------------------  469 (873)
T ss_pred             CcccceecCCCCcceeecccccccchhhhhhhcccceEEeccHHHHHHHHHhccc-------------------------
Confidence            9999999999999999999988544999999999999999999999999974311                         


Q ss_pred             hhhhhhhhhcCCcceeeccccccCCCCcccCCcccccCCCccccCCc
Q psy3330         492 AQRVDRIIKNNHSLTIVLNNLKCSSPPDIKGLEVKAVPENSVHCESN  538 (608)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~C~~p~~~~g~~~~~~~~~~~~C~~~  538 (608)
                                     .......|++|+++.|+.+..++..++.|++.
T Consensus       470 ---------------q~sv~a~CayPe~Lad~~i~svd~~~lvC~Ds  501 (873)
T KOG4194|consen  470 ---------------QSSVIAKCAYPEPLADQSIVSVDTANLVCDDS  501 (873)
T ss_pred             ---------------ccceeeeccCCcccccceeEeechhhceecCC
Confidence                           12235689999999999999999999999864



>KOG4237|consensus Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>KOG4194|consensus Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>KOG0472|consensus Back     alignment and domain information
>KOG0444|consensus Back     alignment and domain information
>KOG0472|consensus Back     alignment and domain information
>KOG0444|consensus Back     alignment and domain information
>KOG4237|consensus Back     alignment and domain information
>KOG0618|consensus Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>KOG0618|consensus Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>KOG0617|consensus Back     alignment and domain information
>KOG0617|consensus Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>KOG1259|consensus Back     alignment and domain information
>KOG3207|consensus Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG3207|consensus Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG1909|consensus Back     alignment and domain information
>KOG0532|consensus Back     alignment and domain information
>KOG0532|consensus Back     alignment and domain information
>KOG0531|consensus Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG1259|consensus Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG1909|consensus Back     alignment and domain information
>KOG0531|consensus Back     alignment and domain information
>TIGR00864 PCC polycystin cation channel protein Back     alignment and domain information
>KOG4658|consensus Back     alignment and domain information
>KOG4658|consensus Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG1859|consensus Back     alignment and domain information
>KOG1644|consensus Back     alignment and domain information
>KOG1859|consensus Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>KOG1644|consensus Back     alignment and domain information
>KOG4579|consensus Back     alignment and domain information
>KOG2982|consensus Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>smart00082 LRRCT Leucine rich repeat C-terminal domain Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG2120|consensus Back     alignment and domain information
>KOG2982|consensus Back     alignment and domain information
>KOG4579|consensus Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>KOG2120|consensus Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG3665|consensus Back     alignment and domain information
>smart00013 LRRNT Leucine rich repeat N-terminal domain Back     alignment and domain information
>PF01462 LRRNT: Leucine rich repeat N-terminal domain; InterPro: IPR000372 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>KOG3665|consensus Back     alignment and domain information
>KOG2739|consensus Back     alignment and domain information
>KOG2123|consensus Back     alignment and domain information
>KOG2123|consensus Back     alignment and domain information
>KOG4341|consensus Back     alignment and domain information
>KOG4341|consensus Back     alignment and domain information
>KOG2739|consensus Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>PF01463 LRRCT: Leucine rich repeat C-terminal domain; InterPro: IPR000483 Leucine-rich repeats (LRR, see IPR001611 from INTERPRO) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>smart00370 LRR Leucine-rich repeats, outliers Back     alignment and domain information
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily Back     alignment and domain information
>KOG1947|consensus Back     alignment and domain information
>KOG1947|consensus Back     alignment and domain information
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily Back     alignment and domain information
>smart00370 LRR Leucine-rich repeats, outliers Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>KOG3864|consensus Back     alignment and domain information
>KOG0473|consensus Back     alignment and domain information
>KOG0473|consensus Back     alignment and domain information
>smart00364 LRR_BAC Leucine-rich repeats, bacterial type Back     alignment and domain information
>KOG4308|consensus Back     alignment and domain information
>smart00365 LRR_SD22 Leucine-rich repeat, SDS22-like subfamily Back     alignment and domain information
>KOG3864|consensus Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query608
2wfh_A193 The Human Slit 2 Dimerization Domain D4 Length = 19 3e-15
2wfh_A193 The Human Slit 2 Dimerization Domain D4 Length = 19 5e-05
2id5_A477 Crystal Structure Of The Lingo-1 Ectodomain Length 8e-15
3kj4_A286 Structure Of Rat Nogo Receptor Bound To 1d9 Antagon 1e-13
1p8t_A285 Crystal Structure Of Nogo-66 Receptor Length = 285 4e-13
1ozn_A285 1.5a Crystal Structure Of The Nogo Receptor Ligand 4e-13
3m19_A251 Crystal Structure Of Variable Lymphocyte Receptor V 1e-09
3m18_A251 Crystal Structure Of Variable Lymphocyte Receptor V 1e-09
3zyj_A440 Netring1 In Complex With Ngl1 Length = 440 2e-09
2o6s_A208 Structural Diversity Of The Hagfish Variable Lympho 3e-09
3v47_A455 Crystal Structure Of The N-Tetminal Fragment Of Zeb 3e-09
3v47_A455 Crystal Structure Of The N-Tetminal Fragment Of Zeb 2e-05
1xcd_A329 Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo 1e-08
1xku_A330 Crystal Structure Of The Dimeric Protein Core Of De 1e-08
3zyi_A452 Netring2 In Complex With Ngl2 Length = 452 1e-08
2o6q_A270 Structural Diversity Of The Hagfish Variable Lympho 4e-08
2ft3_A332 Crystal Structure Of The Biglycan Dimer Core Protei 5e-08
3e6j_A229 Crystal Structure Of Variable Lymphocyte Receptor ( 6e-08
2v9s_A220 Second Lrr Domain Of Human Slit2 Length = 220 8e-08
3rfs_A272 Design Of A Binding Scaffold Based On Variable Lymp 8e-08
2v9t_B220 Complex Between The Second Lrr Domain Of Slit2 And 9e-08
3zyn_A321 Crystal Structure Of The N-Terminal Leucine Rich Re 2e-07
3zyo_A411 Crystal Structure Of The N-Terminal Leucine Rich Re 2e-07
2v70_A220 Third Lrr Domain Of Human Slit2 Length = 220 5e-07
1w8a_A192 Third Lrr Domain Of Drosophila Slit Length = 192 6e-07
2z66_A306 Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A 1e-06
3cig_A697 Crystal Structure Of Mouse Tlr3 Ectodomain Length = 1e-06
2z80_A353 Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu 3e-06
2z7x_A549 Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu 4e-06
3j0a_A844 Homology Model Of Human Toll-Like Receptor 5 Fitted 5e-06
3v44_A407 Crystal Structure Of The N-Terminal Fragment Of Zeb 1e-05
1ziw_A680 Human Toll-Like Receptor 3 Extracellular Domain Str 1e-05
3g3a_A178 Structure Of A Lamprey Variable Lymphocyte Receptor 1e-05
3ulu_A694 Structure Of Quaternary Complex Of Human Tlr3ecd Wi 1e-05
2a0z_A705 The Molecular Structure Of Toll-like Receptor 3 Lig 2e-05
3g3b_A170 Structure Of A Lamprey Variable Lymphocyte Receptor 2e-05
2o6r_A177 Structural Diversity Of The Hagfish Variable Lympho 2e-05
3g39_A170 Structure Of A Lamprey Variable Lymphocyte Receptor 4e-05
2xot_A361 Crystal Structure Of Neuronal Leucine Rich Repeat P 8e-05
1gwb_B281 Structure Of Glycoprotein 1b Length = 281 2e-04
3t6q_A606 Crystal Structure Of Mouse Rp105MD-1 Complex Length 2e-04
1p8v_A279 Crystal Structure Of The Complex Of Platelet Recept 2e-04
1ook_G290 Crystal Structure Of The Complex Of Platelet Recept 2e-04
3pmh_G290 Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib 2e-04
2z62_A276 Crystal Structure Of The Tv3 Hybrid Of Human Tlr4 A 2e-04
3ul9_A278 Structure Of The Tv3 Mutant M41e Length = 278 2e-04
2r9u_A174 Crystal Structure Of Lamprey Variable Lymphocyte Re 2e-04
3ul7_A278 Crystal Structure Of The Tv3 Mutant F63w Length = 2 2e-04
3ula_A279 Crystal Structure Of The Tv3 Mutant F63w-Md-2-Erito 2e-04
1p9a_G290 Crystal Structure Of N-terminal Domain Of Human Pla 2e-04
3ul8_A279 Crystal Structure Of The Tv3 Mutant V134l Length = 3e-04
3rg1_A612 Crystal Structure Of The Rp105MD-1 Complex Length = 3e-04
3o6n_A390 Crystal Structure Of Apl1 Leucine-Rich Repeat Domai 5e-04
2z81_A549 Crystal Structure Of The Tlr1-tlr2 Heterodimer Indu 6e-04
1sq0_B288 Crystal Structure Of The Complex Of The Wild-Type V 6e-04
3a79_A580 Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len 7e-04
1u0n_D265 The Ternary Von Willebrand Factor A1-Glycoprotein I 7e-04
2z63_A570 Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A 8e-04
3p72_A269 Structure Of Platelet Glycoprotein 1b Alpha With A 8e-04
>pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 Back     alignment and structure

Iteration: 1

Score = 80.5 bits (197), Expect = 3e-15, Method: Compositional matrix adjust. Identities = 49/135 (36%), Positives = 73/135 (54%), Gaps = 2/135 (1%) Query: 22 CPSRCQCFDQKLEASCTDAGLEVVPIQLNPEVQTIILRENRISNVHYTLSFYIELRSLDL 81 CP+ C C D + C++ GL+V+P + +V + L N+ + V LS Y L +DL Sbjct: 4 CPTECTCLDTVVR--CSNKGLKVLPKGIPRDVTELYLDGNQFTLVPKELSNYKHLTLIDL 61 Query: 82 SVNKINVLGSHNFEYQNKLLNLNISYNEISALSKDTFKGLKELKTLDLSYNKISVINKTA 141 S N+I+ L + +F +LL L +SYN + + TF GLK L+ L L N ISV+ + A Sbjct: 62 SNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGA 121 Query: 142 FRDTLHLELLILSFN 156 F D L L + N Sbjct: 122 FNDLSALSHLAIGAN 136
>pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 Back     alignment and structure
>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 Back     alignment and structure
>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 Back     alignment and structure
>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 Back     alignment and structure
>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 Back     alignment and structure
>pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 Back     alignment and structure
>pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 Back     alignment and structure
>pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 Back     alignment and structure
>pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 Back     alignment and structure
>pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 Back     alignment and structure
>pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 Back     alignment and structure
>pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329 Back     alignment and structure
>pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330 Back     alignment and structure
>pdb|3ZYI|A Chain A, Netring2 In Complex With Ngl2 Length = 452 Back     alignment and structure
>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 Back     alignment and structure
>pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332 Back     alignment and structure
>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 Back     alignment and structure
>pdb|2V9S|A Chain A, Second Lrr Domain Of Human Slit2 Length = 220 Back     alignment and structure
>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 Back     alignment and structure
>pdb|2V9T|B Chain B, Complex Between The Second Lrr Domain Of Slit2 And The First Ig Domain From Robo1 Length = 220 Back     alignment and structure
>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 Back     alignment and structure
>pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 Back     alignment and structure
>pdb|2V70|A Chain A, Third Lrr Domain Of Human Slit2 Length = 220 Back     alignment and structure
>pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 Back     alignment and structure
>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 Back     alignment and structure
>pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 Back     alignment and structure
>pdb|2Z80|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 353 Back     alignment and structure
>pdb|2Z7X|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 549 Back     alignment and structure
>pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 Back     alignment and structure
>pdb|3V44|A Chain A, Crystal Structure Of The N-Terminal Fragment Of Zebrafish Tlr5 Length = 407 Back     alignment and structure
>pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680 Back     alignment and structure
>pdb|3G3A|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor In Complex With A Protein Antigen Length = 178 Back     alignment and structure
>pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694 Back     alignment and structure
>pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705 Back     alignment and structure
>pdb|3G3B|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor Mutant In Complex With A Protein Antigen Length = 170 Back     alignment and structure
>pdb|2O6R|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B61 Length = 177 Back     alignment and structure
>pdb|3G39|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor Length = 170 Back     alignment and structure
>pdb|2XOT|A Chain A, Crystal Structure Of Neuronal Leucine Rich Repeat Protein Amigo-1 Length = 361 Back     alignment and structure
>pdb|1GWB|B Chain B, Structure Of Glycoprotein 1b Length = 281 Back     alignment and structure
>pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606 Back     alignment and structure
>pdb|1P8V|A Chain A, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Alpha-thrombin At 2.6a Length = 279 Back     alignment and structure
>pdb|1OOK|G Chain G, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Human Alpha-thrombin Length = 290 Back     alignment and structure
>pdb|3PMH|G Chain G, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib Interaction With Two Distinct Alpha-Thrombin Sites Length = 290 Back     alignment and structure
>pdb|2Z62|A Chain A, Crystal Structure Of The Tv3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 276 Back     alignment and structure
>pdb|3UL9|A Chain A, Structure Of The Tv3 Mutant M41e Length = 278 Back     alignment and structure
>pdb|2R9U|A Chain A, Crystal Structure Of Lamprey Variable Lymphocyte Receptor 2913 Ectodomain Length = 174 Back     alignment and structure
>pdb|3UL7|A Chain A, Crystal Structure Of The Tv3 Mutant F63w Length = 278 Back     alignment and structure
>pdb|3ULA|A Chain A, Crystal Structure Of The Tv3 Mutant F63w-Md-2-Eritoran Complex Length = 279 Back     alignment and structure
>pdb|1P9A|G Chain G, Crystal Structure Of N-terminal Domain Of Human Platelet Receptor Glycoprotein Ib-alpha At 1.7 Angstrom Resolution Length = 290 Back     alignment and structure
>pdb|3UL8|A Chain A, Crystal Structure Of The Tv3 Mutant V134l Length = 279 Back     alignment and structure
>pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612 Back     alignment and structure
>pdb|3O6N|A Chain A, Crystal Structure Of Apl1 Leucine-Rich Repeat Domain Length = 390 Back     alignment and structure
>pdb|2Z81|A Chain A, Crystal Structure Of The Tlr1-tlr2 Heterodimer Induced By Binding Of A Tri-acylated Lipopeptide Length = 549 Back     alignment and structure
>pdb|1SQ0|B Chain B, Crystal Structure Of The Complex Of The Wild-Type Von Willebrand Factor A1 Domain And Glycoprotein Ib Alpha At 2.6 Angstrom Resolution Length = 288 Back     alignment and structure
>pdb|3A79|A Chain A, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 580 Back     alignment and structure
>pdb|1U0N|D Chain D, The Ternary Von Willebrand Factor A1-Glycoprotein Ibalpha- Botrocetin Complex Length = 265 Back     alignment and structure
>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 Back     alignment and structure
>pdb|3P72|A Chain A, Structure Of Platelet Glycoprotein 1b Alpha With A Bound Peptide Inhibitor Length = 269 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query608
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 6e-74
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 4e-56
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 1e-44
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 4e-12
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 3e-54
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 2e-44
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 7e-19
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 8e-14
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 3e-54
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 2e-45
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 5e-14
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 4e-52
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 3e-42
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 6e-34
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 8e-17
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 4e-51
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 9e-17
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 7e-08
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 6e-51
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 4e-49
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 4e-47
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 2e-42
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 3e-50
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 4e-49
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 3e-36
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 2e-28
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 8e-48
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 7e-35
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 1e-17
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 1e-47
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 4e-45
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 7e-44
3j0a_A844 TOLL-like receptor 5; membrane protein, leucine-ri 2e-39
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 6e-14
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 2e-46
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 4e-33
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 5e-45
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 5e-39
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 1e-28
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 1e-19
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 8e-45
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 1e-35
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 8e-30
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 4e-29
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 3e-06
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 4e-44
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 2e-35
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 8e-25
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 9e-17
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 8e-44
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 8e-33
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 9e-32
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 3e-23
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 5e-16
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 1e-42
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 1e-31
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 8e-23
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 3e-17
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 7e-39
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 6e-37
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 3e-04
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 1e-37
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 4e-37
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 2e-33
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 4e-30
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 2e-27
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 8e-25
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 7e-37
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 3e-29
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 2e-28
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 1e-23
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 1e-04
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 3e-35
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 2e-27
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 3e-35
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 4e-22
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 3e-34
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 1e-28
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 1e-23
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 9e-20
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 7e-14
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 1e-10
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 9e-34
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 2e-29
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 8e-33
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 3e-25
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 9e-23
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 1e-31
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 6e-27
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 4e-18
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 2e-30
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 1e-22
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 3e-18
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 2e-10
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 4e-07
4fmz_A347 Internalin; leucine rich repeat, structural genomi 2e-29
4fmz_A347 Internalin; leucine rich repeat, structural genomi 2e-28
4fmz_A347 Internalin; leucine rich repeat, structural genomi 3e-26
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 7e-29
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 7e-23
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 2e-22
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 2e-21
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 5e-21
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 3e-18
2z7x_B 520 TOLL-like receptor 1, variable lymphocyte recepto; 5e-09
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 2e-28
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 5e-20
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 2e-18
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 9e-18
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 4e-17
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 5e-27
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 2e-19
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 1e-17
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 1e-15
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 8e-13
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 1e-26
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 1e-25
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 4e-21
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 4e-08
1o6v_A466 Internalin A; bacterial infection, extracellular r 3e-26
1o6v_A466 Internalin A; bacterial infection, extracellular r 3e-25
1o6v_A466 Internalin A; bacterial infection, extracellular r 1e-21
1o6v_A466 Internalin A; bacterial infection, extracellular r 7e-20
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 2e-25
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 3e-24
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 9e-21
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 1e-20
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 9e-25
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 9e-22
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 4e-19
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 5e-13
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 3e-04
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 2e-24
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 1e-20
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 3e-14
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 9e-13
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 5e-23
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 6e-20
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 9e-20
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 5e-23
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 1e-20
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 6e-17
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 1e-22
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 1e-21
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 4e-20
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 5e-18
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 2e-16
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 2e-09
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 5e-09
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 5e-21
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 3e-18
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 2e-13
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 9e-06
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 8e-21
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 1e-20
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 3e-09
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 6e-19
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 1e-16
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 2e-16
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 1e-05
3m19_A251 Variable lymphocyte receptor A diversity region; a 7e-19
3m19_A251 Variable lymphocyte receptor A diversity region; a 1e-18
3m19_A251 Variable lymphocyte receptor A diversity region; a 6e-17
3m19_A251 Variable lymphocyte receptor A diversity region; a 5e-07
3m19_A251 Variable lymphocyte receptor A diversity region; a 1e-06
4ezg_A197 Putative uncharacterized protein; internalin-A, le 7e-18
4ezg_A197 Putative uncharacterized protein; internalin-A, le 5e-15
4ezg_A197 Putative uncharacterized protein; internalin-A, le 2e-14
4ezg_A197 Putative uncharacterized protein; internalin-A, le 2e-14
4ezg_A197 Putative uncharacterized protein; internalin-A, le 5e-11
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 2e-17
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 4e-17
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 7e-13
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 2e-08
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 1e-16
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 4e-15
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 2e-11
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 4e-11
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 1e-15
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 4e-15
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 6e-11
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 2e-05
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 2e-14
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 3e-12
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 2e-10
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 2e-04
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 3e-14
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 4e-09
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 1e-06
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 3e-14
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 4e-11
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 1e-04
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 3e-14
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 6e-14
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 2e-11
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 5e-10
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 6e-10
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 6e-14
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 1e-13
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 4e-11
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 7e-11
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 7e-11
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 5e-07
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 8e-14
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 3e-09
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 9e-14
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 1e-10
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 3e-10
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 2e-09
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 2e-04
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 1e-13
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 1e-09
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 6e-06
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 2e-13
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 2e-09
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 3e-13
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 2e-12
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 6e-11
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 7e-11
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 6e-05
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 1e-04
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 3e-13
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 8e-10
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 5e-06
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 4e-13
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 1e-09
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 2e-07
1w8a_A192 SLIT protein; signaling protein, secreted protein, 5e-13
1w8a_A192 SLIT protein; signaling protein, secreted protein, 7e-11
1w8a_A192 SLIT protein; signaling protein, secreted protein, 3e-10
3e6j_A229 Variable lymphocyte receptor diversity region; var 5e-13
3e6j_A229 Variable lymphocyte receptor diversity region; var 1e-10
3e6j_A229 Variable lymphocyte receptor diversity region; var 4e-05
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 2e-12
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 3e-09
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 8e-05
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 8e-04
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 7e-12
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 3e-10
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 1e-09
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 2e-04
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 2e-09
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 6e-09
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-05
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 1e-08
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 5e-07
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 6e-07
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 2e-06
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 4e-05
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 3e-06
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 2e-04
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 1e-04
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 6e-04
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 7e-04
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 1e-04
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 3e-04
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 5e-04
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 7e-04
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 9e-04
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
 Score =  243 bits (622), Expect = 6e-74
 Identities = 105/516 (20%), Positives = 170/516 (32%), Gaps = 140/516 (27%)

Query: 22  CPSRCQCFDQKLEASCTDAGLEVVPIQLNPEVQTIILRENRISNVHYTLSFYIELRSLDL 81
           CP RC+C  Q     C       VP  +  E                        R LDL
Sbjct: 3   CPPRCECSAQDRAVLCHRKRFVAVPEGIPTE-----------------------TRLLDL 39

Query: 82  SVNKINVLGSHNFEYQNKLLNLNISYNEISALSKDTFKGLKELKTLDLSYNKISVINKTA 141
             N+I  L    F     L  L ++ N +SA+    F  L  L+TL L  N++ +I    
Sbjct: 40  GKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGV 99

Query: 142 FRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKLDNNQILDVPNNVLSNLPHQSLHY 201
           F    +L  L +S N I    D  +F  L +L+ L++ +N ++ + +   S L   SL  
Sbjct: 100 FTGLSNLTKLDISENKIVILLDY-MFQDLYNLKSLEVGDNDLVYISHRAFSGLN--SLEQ 156

Query: 202 LYLNENLIETVLDNSFPFTLTNLHTLALSSNIISFINESSFVTLRTLHSLDLSNNNLSAI 261
           L L +  + ++   +    L  L  L L    I+ I + SF  L  L  L++S+      
Sbjct: 157 LTLEKCNLTSIPTEAL-SHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215

Query: 262 PTKQLSKLSALVNLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQPLSLSLPPL 321
            T        L +L ++  N + +  +A + L  L+                        
Sbjct: 216 MTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR------------------------ 251

Query: 322 LLSLSIPLAFSLTPLGTLKCDRLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSIDQ 381
                                 L+LS N  S I+      L  L+ +++           
Sbjct: 252 ---------------------FLNLSYNPISTIEGSMLHELLRLQEIQLV---------- 280

Query: 382 RAFVDNIQLETVIINENMNLKQLPSKLFQGNTNLKSVSLKGNSLSHLEASHF-PLERISF 440
                              L  +    F+G   L+ +++ GN L+ LE S F  +  +  
Sbjct: 281 ----------------GGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLET 324

Query: 441 LDLSDNPLHCDCNLLWLWILVQLQVKSTMETTTVAYEMTSNTSISPGTTTEAQRVDRIIK 500
           L L  NPL CDC LLW++                                         +
Sbjct: 325 LILDSNPLACDCRLLWVF-----------------------------------------R 343

Query: 501 NNHSLTIVLNNLKCSSPPDIKGLEVKAVPENSVHCE 536
               L        C++P  ++G E K  P+  +   
Sbjct: 344 RRWRLNFNRQQPTCATPEFVQGKEFKDFPDVLLPNY 379


>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Length = 329 Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Length = 329 Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query608
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 100.0
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 100.0
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 100.0
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 100.0
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 100.0
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 100.0
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 100.0
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 100.0
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 100.0
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 100.0
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 100.0
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 100.0
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 100.0
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 100.0
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 100.0
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 100.0
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 100.0
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 100.0
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 100.0
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 100.0
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 100.0
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 100.0
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 100.0
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 100.0
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 100.0
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 100.0
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 100.0
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 100.0
1o6v_A466 Internalin A; bacterial infection, extracellular r 100.0
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 100.0
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 100.0
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 100.0
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 100.0
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 100.0
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 100.0
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 100.0
1o6v_A466 Internalin A; bacterial infection, extracellular r 100.0
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 100.0
4fmz_A347 Internalin; leucine rich repeat, structural genomi 100.0
4fmz_A347 Internalin; leucine rich repeat, structural genomi 100.0
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 100.0
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 100.0
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 100.0
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 100.0
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 100.0
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 100.0
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 100.0
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 100.0
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.98
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.98
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.97
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.96
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.96
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.96
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.96
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.96
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.96
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.96
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.96
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.95
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.95
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.95
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.95
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.95
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.95
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.95
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.94
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.94
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.94
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.93
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.93
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 99.93
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.93
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.93
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 99.92
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.92
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.92
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.92
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.92
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.92
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.92
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.91
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.91
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.91
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.91
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.91
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.91
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.9
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.9
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 99.89
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.89
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.89
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.88
1w8a_A192 SLIT protein; signaling protein, secreted protein, 99.88
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.88
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.88
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.88
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.88
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.87
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 99.85
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 99.85
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.85
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.85
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.85
4fdw_A401 Leucine rich hypothetical protein; putative cell s 99.84
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.84
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.84
4fdw_A401 Leucine rich hypothetical protein; putative cell s 99.84
1w8a_A192 SLIT protein; signaling protein, secreted protein, 99.83
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.83
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.82
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.82
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 99.81
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 99.81
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 99.81
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.81
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 99.8
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.79
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 99.79
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.78
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 99.77
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 99.76
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 99.76
4gt6_A394 Cell surface protein; leucine rich repeats, putati 99.76
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 99.75
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.75
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 99.74
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.73
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.73
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.72
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 99.71
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 99.71
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.7
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 99.7
4gt6_A394 Cell surface protein; leucine rich repeats, putati 99.7
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.69
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.67
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 99.65
4b8c_D727 Glucose-repressible alcohol dehydrogenase transcr 99.63
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.63
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.62
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 99.6
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 99.59
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.58
4b8c_D727 Glucose-repressible alcohol dehydrogenase transcr 99.58
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.56
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.54
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 99.51
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 99.48
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.37
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.3
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 99.18
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 99.16
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 98.72
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 98.65
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 98.35
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 98.29
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 98.28
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 98.17
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 98.12
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.08
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 97.86
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 96.91
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 96.58
2lz0_A100 Uncharacterized protein; hypothetical leucine rich 93.17
2lz0_A100 Uncharacterized protein; hypothetical leucine rich 89.16
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
Probab=100.00  E-value=1.1e-53  Score=487.76  Aligned_cols=522  Identities=23%  Similarity=0.293  Sum_probs=343.8

Q ss_pred             CceecCCceEEEecCCCCccccCccCccccEEEeccCCCcccc-cccccCCCccEEEeeCC-CCcccCcccccccccccE
Q psy3330          25 RCQCFDQKLEASCTDAGLEVVPIQLNPEVQTIILRENRISNVH-YTLSFYIELRSLDLSVN-KINVLGSHNFEYQNKLLN  102 (608)
Q Consensus        25 ~C~c~~~~~~v~C~~~~l~~ip~~~~~~l~~L~L~~n~i~~l~-~~~~~~~~L~~L~Ls~n-~l~~i~~~~f~~l~~L~~  102 (608)
                      .|.|.  ...++|++.+++.||. +|+++++|+|++|.++.++ .+|.++++|++|+|++| .+..+++.+|+++++|++
T Consensus         1 ~C~~~--~~~~dcs~~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~   77 (844)
T 3j0a_A            1 SCSFD--GRIAFYRFCNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRI   77 (844)
T ss_dssp             CCBTT--TEEEEESCCCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCE
T ss_pred             CceEe--ceEEEccCCCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCE
Confidence            36664  4789999999999999 9999999999999999875 58999999999999999 566788889999999999


Q ss_pred             EEccCCCCCCCChhhhcCCCcCcEeeccCCcCCccChh--hhCCCCCCcEEEccCCCCCccCchhhhcCCCCccEEEccC
Q psy3330         103 LNISYNEISALSKDTFKGLKELKTLDLSYNKISVINKT--AFRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKLDN  180 (608)
Q Consensus       103 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~  180 (608)
                      |+|++|.++.+.+++|.++++|++|+|++|.+++..+.  .|.++++|++|++++|.+.+...+..|+++++|++|++++
T Consensus        78 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~  157 (844)
T 3j0a_A           78 LDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS  157 (844)
T ss_dssp             EECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEES
T ss_pred             EECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCC
Confidence            99999999999889999999999999999999874333  4889999999999999998876446789999999999999


Q ss_pred             CCCCCCCcccccCC------------------------------------------------------------------
Q psy3330         181 NQILDVPNNVLSNL------------------------------------------------------------------  194 (608)
Q Consensus       181 n~l~~~~~~~~~~l------------------------------------------------------------------  194 (608)
                      |.+..+.+..+..+                                                                  
T Consensus       158 N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~  237 (844)
T 3j0a_A          158 NQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLI  237 (844)
T ss_dssp             SCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEE
T ss_pred             CcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCccccccee
Confidence            88765433222110                                                                  


Q ss_pred             --------------------------CCCCceEEEccCCCCccccCCCccccCCCccEEEccCCCCCccCcccccCCCcc
Q psy3330         195 --------------------------PHQSLHYLYLNENLIETVLDNSFPFTLTNLHTLALSSNIISFINESSFVTLRTL  248 (608)
Q Consensus       195 --------------------------~~~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  248 (608)
                                                ...+++.|++++|.+.+..+..|.. +++|+.|++++|.++++.+..|.++++|
T Consensus       238 l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~L~~n~i~~~~~~~~~~l~~L  316 (844)
T 3j0a_A          238 LAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFET-LKDLKVLNLAYNKINKIADEAFYGLDNL  316 (844)
T ss_dssp             CCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSS-CCCCCEEEEESCCCCEECTTTTTTCSSC
T ss_pred             cccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhc-CCCCCEEECCCCcCCCCChHHhcCCCCC
Confidence                                      0023555555555555555555665 7777777777777777777777777888


Q ss_pred             CEEeccCCcCCCCChhhhhCCCCCCEEeccCCCCCccChhhhCCCCCCceeeccCCCCCCCC------------Cccccc
Q psy3330         249 HSLDLSNNNLSAIPTKQLSKLSALVNLDLSGNNFSNIDSVAFKSLFSLKLVKINLIPNLDSI------------DQPLSL  316 (608)
Q Consensus       249 ~~L~Ls~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~l~~L~~L~l~~~~~l~~~------------~~~~~~  316 (608)
                      ++|++++|+++++++..|.++++|+.|++++|.++.+++.+|..+++|+.|+++++.- ..+            .+.+. 
T Consensus       317 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l-~~i~~~~~L~~L~l~~N~l~-  394 (844)
T 3j0a_A          317 QVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-TTIHFIPSIPDIFLSGNKLV-  394 (844)
T ss_dssp             CEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCS-CCCSSCCSCSEEEEESCCCC-
T ss_pred             CEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCC-CcccCCCCcchhccCCCCcc-
Confidence            8888888888777767777888888888888888777777777788888888765431 110            01100 


Q ss_pred             CCchhhhcc-----c---------------ccc-------------c-cccCCCCCceecEEecCCCCCCC-----cChh
Q psy3330         317 SLPPLLLSL-----S---------------IPL-------------A-FSLTPLGTLKCDRLDLSGNNFSN-----IDSV  357 (608)
Q Consensus       317 ~lp~~~~~~-----~---------------~~~-------------~-~~~~~~~~~~l~~L~ls~n~l~~-----~~~~  357 (608)
                      .+|......     +               ++.             . .........+++.|++++|.+++     ..+.
T Consensus       395 ~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~  474 (844)
T 3j0a_A          395 TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD  474 (844)
T ss_dssp             CCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSS
T ss_pred             cccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchh
Confidence            111110000     0               000             0 00000111233444444444432     2223


Q ss_pred             hhcccccccccccccCCCCCcCChhhhcCCcccceeecccCccccccCcccCCCCCCCCEEEcCCCcccccCCCCCCCCC
Q psy3330         358 AFKSLFSLKLVKINLIPNLDSIDQRAFVDNIQLETVIINENMNLKQLPSKLFQGNTNLKSVSLKGNSLSHLEASHFPLER  437 (608)
Q Consensus       358 ~~~~l~~L~~l~l~~~~~l~~~~~~~f~~l~~L~~L~Ls~N~~l~~lp~~~f~~l~~L~~L~L~~N~l~~l~~~~~~l~~  437 (608)
                      .|.++++|+.|+++. +.++.+++..|.++++|++|+|++|+ ++.+|...|.  ++|+.|+|++|+|+.+++..+  .+
T Consensus       475 ~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~--~~  548 (844)
T 3j0a_A          475 VFEGLSHLQVLYLNH-NYLNSLPPGVFSHLTALRGLSLNSNR-LTVLSHNDLP--ANLEILDISRNQLLAPNPDVF--VS  548 (844)
T ss_dssp             CSSCBCCEECCCCCH-HHHTTCCTTSSSSCCSCSEEEEESCC-CSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC--SS
T ss_pred             hhcCcccccEEECCC-CcccccChhHccchhhhheeECCCCC-CCccChhhhh--ccccEEECCCCcCCCCChhHh--CC
Confidence            455566666666665 55666666666666666666666665 5556655444  566666666666666555443  47


Q ss_pred             CCEEEccCCccccccCChHHHHHHHhhhccccccccceeccCCCccCCCCCccchhhhhhhhhcCCcceeeccccccCCC
Q psy3330         438 ISFLDLSDNPLHCDCNLLWLWILVQLQVKSTMETTTVAYEMTSNTSISPGTTTEAQRVDRIIKNNHSLTIVLNNLKCSSP  517 (608)
Q Consensus       438 L~~L~L~~N~~~CdC~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~p  517 (608)
                      |+.+++++|||.|+|++.||..|.+...                                     ..+.+.+....|.+|
T Consensus       549 L~~l~l~~Np~~C~c~~~~f~~~~~~~~-------------------------------------~~~~~~~~~~~C~~p  591 (844)
T 3j0a_A          549 LSVLDITHNKFICECELSTFINWLNHTN-------------------------------------VTIAGPPADIYCVYP  591 (844)
T ss_dssp             CCEEEEEEECCCCSSSCCSHHHHHHHTT-------------------------------------TTTCCCGGGCCCSSC
T ss_pred             cCEEEecCCCcccccccHHHHHHHHhcC-------------------------------------cccccccccCccCCc
Confidence            8999999999999999999999987321                                     112234567899999


Q ss_pred             CcccCCcccccCCCccccCCcch-----hHHHHHHHHHHHHHHhhee---------eEeehhHHHHhHHHhhc-Cccccc
Q psy3330         518 PDIKGLEVKAVPENSVHCESNTM-----LYVLSFMLLLLSSGVICIL---------MYFIYRKRALWKNKINR-NLKHQS  582 (608)
Q Consensus       518 ~~~~g~~~~~~~~~~~~C~~~~~-----~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~-~~~~~~  582 (608)
                      +.++|.++.+++..  .|.....     +.++++.++++++++++++         .+|++++.+.|...+.+ ..+.+.
T Consensus       592 ~~~~g~~l~~~~~~--~C~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~  669 (844)
T 3j0a_A          592 DSFSGVSLFSLSTE--GCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFCFICYKTAQRLVFKDHPQGTEPDMY  669 (844)
T ss_dssp             SSSCSCCTTTCCCC--CC----------CHHHHHHHHHHHHHHHTTTSHHHHC----------------CCCGGGSSSCC
T ss_pred             hhhCCCccccCccc--cCCchhhccccceehhHHHHHHHHHHHHHHHHHHHHhhhhhhhhHHHHHHHhccccccccccce
Confidence            99999999888765  4865321     1111111111111111111         11222223333322222 223456


Q ss_pred             ccccc--cccCCCcceEE
Q psy3330         583 SYVDN--CMNSHPTPILM  598 (608)
Q Consensus       583 ~~~~~--~~~~~~~~~~~  598 (608)
                      .| ||  ||+++|++||+
T Consensus       670 ~y-d~fisy~~~d~~~v~  686 (844)
T 3j0a_A          670 KY-DAYLCFSSKDFTWVQ  686 (844)
T ss_dssp             CC-SEEEECCSTTHHHHH
T ss_pred             ec-cEEEEeeCCcHHHHH
Confidence            78 99  99999999983



>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>2lz0_A Uncharacterized protein; hypothetical leucine rich repeat protein, structural genomic unknown function; NMR {Bacteroides capillosus} Back     alignment and structure
>2lz0_A Uncharacterized protein; hypothetical leucine rich repeat protein, structural genomic unknown function; NMR {Bacteroides capillosus} Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 608
d1ozna_284 c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept 1e-16
d1ozna_284 c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept 3e-09
d1xkua_305 c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 3e-15
d1xkua_305 c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 1e-10
d1xkua_305 c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 7e-05
d1p9ag_266 c.10.2.7 (G:) von Willebrand factor binding domain 2e-14
d1p9ag_266 c.10.2.7 (G:) von Willebrand factor binding domain 8e-08
d1p9ag_266 c.10.2.7 (G:) von Willebrand factor binding domain 3e-07
d1w8aa_192 c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga 2e-09
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 9e-09
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 4e-06
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 2e-04
d1xwdc1242 c.10.2.7 (C:18-259) Follicle-stimulating hormone r 3e-08
d1xwdc1242 c.10.2.7 (C:18-259) Follicle-stimulating hormone r 7e-04
d1jl5a_353 c.10.2.6 (A:) Leucine rich effector protein YopM { 6e-06
d1jl5a_353 c.10.2.6 (A:) Leucine rich effector protein YopM { 6e-06
d1jl5a_353 c.10.2.6 (A:) Leucine rich effector protein YopM { 3e-05
d1jl5a_353 c.10.2.6 (A:) Leucine rich effector protein YopM { 8e-05
d1jl5a_353 c.10.2.6 (A:) Leucine rich effector protein YopM { 0.001
d1dcea3124 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase 1e-05
d1dcea3124 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase 1e-04
d1dcea3124 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase 7e-04
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 6e-05
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 9e-05
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 3e-04
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 3e-04
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 0.002
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 0.002
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 0.002
d1ogqa_313 c.10.2.8 (A:) Polygalacturonase inhibiting protein 8e-05
d1koha1162 c.10.2.3 (A:201-362) mRNA export factor tap {Human 8e-05
d1a9na_162 c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom 3e-04
d1a9na_162 c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom 5e-04
d1h6ta2210 c.10.2.1 (A:31-240) Internalin B {Listeria monocyt 0.001
d1h6ua2227 c.10.2.1 (A:36-262) Internalin H {Listeria monocyt 0.003
d1h6ua2227 c.10.2.1 (A:36-262) Internalin H {Listeria monocyt 0.004
d2ca6a1344 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom 0.004
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 Back     information, alignment and structure

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]
 Score = 78.3 bits (191), Expect = 1e-16
 Identities = 68/265 (25%), Positives = 104/265 (39%), Gaps = 8/265 (3%)

Query: 22  CPSRCQCFDQ-KLEASCTDAGLEVVPIQLNPEVQTIILRENRISNV-HYTLSFYIELR-S 78
           CP  C C+++ K+  SC   GL+ VP+ +    Q I L  NRIS+V   +      L   
Sbjct: 2   CPGACVCYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTIL 61

Query: 79  LDLSVNKINVLGSHNFEYQNKLLNLNISYNEISALSKDTFKGLKELKTLDLSYNKISVIN 138
              S     +  +                 ++ ++   TF GL  L TL L    +  + 
Sbjct: 62  WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121

Query: 139 KTAFRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKLDNNQILDVPNNVLSNLPHQS 198
              FR    L+ L L  N +    D + F  L +L  L L  N+I  VP      L   S
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPD-DTFRDLGNLTHLFLHGNRISSVPERAFRGLH--S 178

Query: 199 LHYLYLNENLIETVLDNSFPFTLTNLHTLALSSNIISFINESSFVTLRTLHSLDLSNNNL 258
           L  L L++N +  V  ++F   L  L TL L +N +S +   +   LR L  L L++N  
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRD-LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

Query: 259 SAIPTKQLSKLSALVNLDLSGNNFS 283
                +     + L     S +   
Sbjct: 238 VCDC-RARPLWAWLQKFRGSSSEVP 261


>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query608
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 100.0
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 100.0
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.97
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.96
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.95
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.94
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.94
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.93
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.92
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.91
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 99.9
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 99.89
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.87
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.85
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.85
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.83
d2ifga3156 High affinity nerve growth factor receptor, N-term 99.82
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.78
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.77
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.72
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.72
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.71
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.7
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 99.69
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 99.62
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.61
d2ifga3156 High affinity nerve growth factor receptor, N-term 99.61
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.57
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.56
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.52
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.44
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.43
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 99.37
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 99.34
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 99.26
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 99.25
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 98.41
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 98.33
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 97.53
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 97.48
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 96.72
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 96.44
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00  E-value=3.4e-34  Score=282.15  Aligned_cols=196  Identities=27%  Similarity=0.463  Sum_probs=116.1

Q ss_pred             CCCCCceec-CCceEEEecCCCCccccCccCccccEEEeccCCCccccc-ccccCCCccEEEeeCCCCcccCcccccccc
Q psy3330          21 ICPSRCQCF-DQKLEASCTDAGLEVVPIQLNPEVQTIILRENRISNVHY-TLSFYIELRSLDLSVNKINVLGSHNFEYQN   98 (608)
Q Consensus        21 ~Cp~~C~c~-~~~~~v~C~~~~l~~ip~~~~~~l~~L~L~~n~i~~l~~-~~~~~~~L~~L~Ls~n~l~~i~~~~f~~l~   98 (608)
                      +||..|.|. ..+..|.|++.+++++|..+|+++++|+|++|+|+.+|+ +|.++++|++|++++|++..++...+.++.
T Consensus         1 ~cp~~C~C~~~~~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~   80 (284)
T d1ozna_           1 PCPGACVCYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA   80 (284)
T ss_dssp             CCCTTCEEECSSSCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred             CcCCCCEEcCCCCeEEEcCCCCCCccCCCCCCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccc
Confidence            599999996 456789999999999999998888877777777766654 455555555555555555555554444444


Q ss_pred             cccEEEccCCCCCCCChhhhcCCCcCcEeeccCCcCCccChhhhCCCCCCcEEEccCCCCCccCchhhhcCCCCccEEEc
Q psy3330          99 KLLNLNISYNEISALSKDTFKGLKELKTLDLSYNKISVINKTAFRDTLHLELLILSFNNITYFEDSEIFSSLKSLRILKL  178 (608)
Q Consensus        99 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L  178 (608)
                      .++.++..                       ..+.++.+++..|.++++|++|++++|.+..+. +..+....+|+.+++
T Consensus        81 ~~~~l~~~-----------------------~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~-~~~~~~~~~L~~l~l  136 (284)
T d1ozna_          81 LLEQLDLS-----------------------DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG-PGLFRGLAALQYLYL  136 (284)
T ss_dssp             TCCEEECC-----------------------SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCC-TTTTTTCTTCCEEEC
T ss_pred             cccccccc-----------------------cccccccccchhhcccccCCEEecCCccccccc-ccccchhcccchhhh
Confidence            44444432                       233444555555666666666666666655544 334444444444444


Q ss_pred             cCCCCCCCCcccccCCCCCCceEEEccCCCCccccCCCccccCCCccEEEccCCCCCccCcccccCCCccCEEeccCCcC
Q psy3330         179 DNNQILDVPNNVLSNLPHQSLHYLYLNENLIETVLDNSFPFTLTNLHTLALSSNIISFINESSFVTLRTLHSLDLSNNNL  258 (608)
Q Consensus       179 ~~n~l~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l  258 (608)
                      ++|.++.+++                                                   ..|..+++|+.|++++|++
T Consensus       137 ~~N~l~~i~~---------------------------------------------------~~f~~~~~L~~L~l~~N~l  165 (284)
T d1ozna_         137 QDNALQALPD---------------------------------------------------DTFRDLGNLTHLFLHGNRI  165 (284)
T ss_dssp             CSSCCCCCCT---------------------------------------------------TTTTTCTTCCEEECCSSCC
T ss_pred             ccccccccCh---------------------------------------------------hHhccccchhhcccccCcc
Confidence            4444433332                                                   2233334455555555555


Q ss_pred             CCCChhhhhCCCCCCEEeccCCCCCccChhhhC
Q psy3330         259 SAIPTKQLSKLSALVNLDLSGNNFSNIDSVAFK  291 (608)
Q Consensus       259 ~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~  291 (608)
                      +.+++.+|.++++|+.+++++|+++++.+..|.
T Consensus       166 ~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~  198 (284)
T d1ozna_         166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR  198 (284)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred             cccchhhhccccccchhhhhhccccccChhHhh
Confidence            555555566666666666666666555544443



>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure